CO2Lift V hypercarbotherapy is integrated into Advanced Pelvic Surgery's post-surgical recovery protocols, in-office wellness visits, and at-home maintenance, applying a validated physiological mechanism to improve tissue hydration, elasticity, and healing without hormones or downtime.
The Mechanism:
Transcutaneous Hyperoxygenation
CO2Lift V Therapy (Transcutaneous Hypercarbotherapy) is a well-tolerated, non-invasive treatment that applies a fundamental biological principle to enhance blood flow, oxygenation, and neoangiogenesis in pelvic tissues.
The Bohr Effect
Named after physiologist Christian Bohr, this phenomenon describes how carbon dioxide concentration governs oxygen release from hemoglobin.
During a CO2Lift V session, a medical-grade carboxytherapy gel is applied directly to the vulvovaginal tissues. The localized transdermal absorption of CO₂ signals an oxygen deficit to circulating red blood cells. In immediate response, hemoglobin releases its bound oxygen, flooding the targeted tissue with oxygenated, nutrient-rich blood.
This surge in local oxygen concentration stimulates microcirculation, reduces inflammatory mediators, promotes neoangiogenesis, and initiates cellular repair — without systemic hormone exposure.